SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014533
Filing Date
2023-08-10
Accepted
2023-08-10 16:59:40
Documents
58
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycc-20230630x10q.htm   iXBRL 10-Q 1190554
2 EX-31.1 cycc-20230630xex31d1.htm EX-31.1 14688
3 EX-31.2 cycc-20230630xex31d2.htm EX-31.2 15230
4 EX-32.1 cycc-20230630xex32d1.htm EX-32.1 5091
5 EX-32.2 cycc-20230630xex32d2.htm EX-32.2 5435
  Complete submission text file 0001558370-23-014533.txt   5038151

Data Files

Seq Description Document Type Size
6 EX-101.SCH cycc-20230630.xsd EX-101.SCH 36977
7 EX-101.CAL cycc-20230630_cal.xml EX-101.CAL 34482
8 EX-101.DEF cycc-20230630_def.xml EX-101.DEF 188454
9 EX-101.LAB cycc-20230630_lab.xml EX-101.LAB 294233
10 EX-101.PRE cycc-20230630_pre.xml EX-101.PRE 267110
52 EXTRACTED XBRL INSTANCE DOCUMENT cycc-20230630x10q_htm.xml XML 636843
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 231160458
SIC: 2834 Pharmaceutical Preparations